Author

Leslie W. Abad

Observed names: L. Abad, L. W. Abad, LESLIE W. ABAD, Leslie Abad, Leslie W Abad

Institution: Nanostring Technologies (United States)

Observed institutions: Boston University, Tufts University, Indiana University Health, Tufts Medical Center, Pennsylvania State University, United States Department of Agriculture, Harvard University, Eli Lilly (United States), University of Rhode Island, University of Wisconsin–Stevens Point, Spaulding Rehabilitation Hospital, Nanostring Technologies (United States), Jean Mayer Human Nutrition Research Center on Aging, Framingham Heart Study, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

OpenAlex ID: A5087201409

Monocyte Cytokine Production in an Elderly Population: Effect of Age and Inflammation

1998 · R. Roubenoff, T. B. Harris, et al. · The Journals of Gerontology Series A · 419

Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study

2003 · Ronenn Roubenoff, Helen Parise, et al. · The American Journal of Medicine · 397

Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

2009 · Rafael Ponce, Leslie Abad, et al. · Regulatory Toxicology and Pharmacology · 270

Insulin‐Like Growth Factor‐1 and Interleukin 6 Predict Sarcopenia in Very Old Community‐Living Men and Women: The Framingham Heart Study

2003 · Hélène Payette, Ronenn Roubenoff, et al. · Journal of the American Geriatrics Society · 245

Abnormal homocysteine metabolism in rheumatoid arthritis

1997 · Ronenn Roubenoff, Paul Dellaripa, et al. · Arthritis & Rheumatism · 176

Adjuvant arthritis as a model of inflammatory cachexia

1997 · Ronenn Roubenoff, Lisa M. Freeman, et al. · Arthritis & Rheumatism · 163

Effects of progressive resistance training on immune response in aging and chronic inflammation

1996 · LAURA C. RALL, RONENN ROUBENOFF, et al. · Medicine & Science in Sports & Exercise · 153

Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor α

1996 · Laura C. Rall, Clifford J. Rosen, et al. · Arthritis & Rheumatism · 111

A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma

2013 · Ghassan K. Abou-Alfa, Marinela Capanu, et al. · Journal of Hepatology · 98

Eccentric exercise markedly increases c-Jun NH 2 -terminal kinase activity in human skeletal muscle

1999 · Marni D. Boppart, Doron Aronson, et al. · Journal of Applied Physiology · 93

Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis.

2004 · Joseph Walsmith, Leslie Abad, et al. · PubMed · 91

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men

2002 · Ronenn Roubenoff, Steven Grinspoon, et al. · American Journal of Physiology-Endocrinology and Metabolism · 85

Acute Phase Responses and Cytokine Secretion in Chronic Fatigue Syndrome

1999 · Joseph G. Cannon, Jonathan B. Angel, et al. · Journal of Clinical Immunology · 81

Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome

1997 · Joseph G. Cannon, Jonathan B. Angel, et al. · Journal of Clinical Immunology · 65

Effects of prior exercise on eccentric exercise-induced neutrophilia and enzyme release

2000 · ROGER A. FIELDING, MARIONA A. VIOLAN, et al. · Medicine & Science in Sports & Exercise · 54

Cachexia in rheumatoid arthritis is not explained by decreased growth hormone secretion

2002 · Laura C. Rall, Joseph M. Walsmith, et al. · Arthritis & Rheumatism · 42

PDF

Development of a biosensor-based method for detection and isotyping of antibody responses to adenoviral-based gene therapy vectors

2002 · Leslie W Abad, Meredith Neumann, et al. · Analytical Biochemistry · 39

Cytokine Responses Differ by Compartment and Wasting Status in Patients With Hiv Infection and Healthy Controls

2002 · Leslie W. Abad, Heather R. Schmitz, et al. · Cytokine · 26

Hormonal Influences on Stress-Induced Neutrophil Mobilization in Health and Chronic Fatigue Syndrome

1998 · Joseph G. Cannon, Jonathan B. Angel, et al. · Journal of Clinical Immunology · 26

Menstrual- and gender-dependent variations in circulating IL-1 agonists, antagonists, and binding proteins

1998 · Joseph G Cannon, Leslie W Abad, et al. · Journal of Leukocyte Biology · 10

Effect of acquired immune deficiency syndrome wasting on the protein metabolic response to acute exercise

2001 · Ronenn Roubenoff, Leslie W. Abad, et al. · Metabolism · 9

Randomized phase II study of capecitabine with or without ramucirumab (IMC-1121B) or IMC-18F1 in patients with unresectable, locally advanced or metastatic breast cancer (mBC) previously treated with anthracycline and taxane therapy (CP20-0903/NCT01234402).

2011 · L. T. Vahdat, K. Miller, et al. · Journal of Clinical Oncology · 7

Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available.

2011 · R. E. Martell, E. G. Chiorean, et al. · Journal of Clinical Oncology · 4

Randomized phase II study of docetaxel with or without ramucirumab (IMC-1121B) or icrucumab (IMC-18F1) in patients with urothelial transitional cell carcinoma (TCC) following progression on first-line platinum-based therapy.

2012 · Daniel Peter Petrylak, Kim N. Chi, et al. · Journal of Clinical Oncology · 3

Abstract 986: A BioPharma best practices framework to enable successful morphology guided spatial biology studies using NanoString GeoMx® Digital Spatial Profiler

2023 · Leslie Abad, Maxine McClain, et al. · Cancer Research · 1

Works count: 26

Citation count: 2,668

H-index: 19

I10-index: 20